Astellas Pharma Inc

Japan · Reporting entity ID 100000010648

Total reported 2019–2025

$44.7M

#189 of 2,960 reporting companies — 0.1% of all reported industry payments

$1.54M in general payments across 355 records, plus $43.2M in research funding across 9,047 records.

How it breaks down

General payments $1,539,962

Research funding $43,159,973

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.